Covid-19 Articles

Understanding How Testing Works

CITY JOURNAL - APRIL 22, 2020
Peter Kolchinsky, PhD

VIEW PDF

Innovation and Biotech in the Time of COVID-19: What's Happening on the Front Lines

LABCENTRAL - APRIL 21, 2020
Joshua Resnick, MD

RA Capital's Joshua Resnick, MD, joins biotech industry leaders, experts, and entrepreneurs to discuss COVID-19 and its impact on innovation.

The ventilator shortage is here. The medication shortage is next.

THE WASHINGTON POST - APRIL 9, 2020
Joshua Resnick, MD

VIEW PDF

Prospects for a Coronavirus Vaccine

CITY JOURNAL - APRIL 8, 2020
Peter Kolchinsky, PhD

A Cure for the Common Misconception

CITY JOURNAL - APRIL 2020
Peter Kolchinsky, PhD

VIEW PDF

Ending Covid

CITY JOURNAL - MARCH 31, 2020
Peter Kolchinsky, PhD

VIEW PDF

RA Capital Management COVID 19 Town Hall

POSTED MARCH 17, 2020
Peter Kolchinsky, Founder and Managing Partner, and Josh Resnick, Managing Director and Co-Head of Venture, share their thoughts on the COVID-19 virus, including how one can mitigate the risks of getting the disease, what one can expect should they contract it, the treatments currently available and those that are on the horizon, and the impact this coronavirus could have on both the healthcare system and the global biotech sector.

Coronavirus spending: an expense — or an investment?

STAT - MARCH 5, 2020
Jessica Sagers, PhD

VIEW PDF

How Do You Price a Pandemic?

CITY JOURNAL - FEBRUARY 24, 2020
Peter Kolchinsky, PhD

VIEW PDF